10 Biggest Price Target Changes For Friday
Piper Sandler raised Adobe Inc. (NASDAQ: ADBE) price target from $570 to $600. Adobe shares rose 3.3% to $569.50 in pre-market trading.
Registration Statement Related To Cleveland BioLabs-Cytocom Merger Declared Effective By SEC
Cleveland BioLabs Inc (NASDAQ:CBLI) says that the SEC registration statement regarding the previously announced merger with Cytocom Inc was declared effective…
28 Stocks Moving in Friday’s Pre-Market Session
Gainers
CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.
Geron Stock Trading Is Higher On Reinforcing Imetelstat’s Approach For Myelofibrosis Treatment, With Data Publication In Journal
Geron Corporation (NASDAQ:GERN) stock is trading higher during the premarket in reaction to data publication from the IMbark Phase 2…
Orphazyme Wild Party At Risk As FDA Rejects Its Rare Neurodegenerative Disease Drug
Orphazyme A/S (NASDAQ: ORPH) shares, which have been extremely volatile of late, could come under pressure Friday
50 Biggest Movers From Yesterday
Gainers
Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share.
Cannabis Stock Gainers And Losers From June 17, 2021
GAINERS:
Invictus MD Strategies (OTC: IVITF) shares closed up 13.46% at $0.06
Gentech Acquires MPB Cookies For Undisclosed Sum
Gentech Holdings Inc (OTC:GTEH) has agreed to acquire MPB Cookies, a high-end protein cookie company that makes gluten-free, high-protein snacks. The…
Mid-Afternoon Market Update: Nasdaq Gains Over 100 Points; CureVac Shares Plummet
Toward the end of trading Thursday, the Dow traded down 0.67% to 33,806.27 while the NASDAQ rose 0.91% to 14,167.03. The S&P also fell, dropping 0.02% to 4,222.94.
Processa Pharmaceuticals In-Licenses Ocuphire’s Anticancer Agent
Processa Pharmaceuticals Inc (NASDAQ:PCSA) has entered into a licensing agreement with Ocuphire Pharma Inc (NASDAQ:OCUP) to in-license RX-3117. RX-3117 is an oral anticancer…